Trial success for breast cancer test
This article was originally published in Clinica
Immunomedics' CEA-Scan test could improve the detection rate of breast cancers, even in women with non-palpable lesions, according to clinical trial results.
You may also be interested in...
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.